‘Don’t make decisions based on fear, make decisions based on information.’
April 22, 2021
A healthcare worker administers a COVID-19 vaccine from Humber River Hospital’s mobile vaccination clinic. (Photo: Cole Burston/Bloomberg via Getty Images)
While provinces across Canada are lowering the age of eligibility for AstraZeneca from 55-plus to 40-plus, the vaccine’s link to extremely rare blood clots may still be a source of hesitancy for many women.
Reports of the vaccine-related clots emerged in early March, with most of the cases in Europe involving women under the age of 55. Canada’s first four cases—out of more than 1.1 million doses of vaccines administered—popped up in April: a Quebec woman over the age of 55; a man from Alberta and a man from Ontario, both in their 60s; and an individual in New Brunswick in their 30s. All of them received the AstraZeneca vaccine.